Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

NCT00673335 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

brca1 Mutation Carrier
brca2 Mutation Carrier
Breast Cancer
Hereditary Breast/Ovarian Cancer (brca1, brca2)

Interventions

DRUG: letrozole
DRUG: Placebo

Sponsor

UNICANCER